$0.57
-4.9%DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Last Annual Value
34.45M
3-Year CAGR
6%
5-Year CAGR
39%
10-Year CAGR
16%
| Company | Net Cash Provided by Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() DocGo Inc. NASDAQ:DCGO | 34.45M | N/A | N/A | N/A | |
![]() Prelude Therapeutics Incorporated NASDAQ:PRLD | -56.30M | N/A | N/A | N/A | |
![]() Microbot Medical Inc. NASDAQ:MBOT | -13.05M | N/A | N/A | N/A | |
![]() Ovid Therapeutics Inc. NASDAQ:OVID | -38.33M | N/A | N/A | N/A | |
![]() Anika Therapeutics, Inc. NASDAQ:ANIK | 11.19M | N/A | 5.9% | -7.3% | |
![]() Apyx Medical Corporation NASDAQ:APYX | -8.00M | N/A | N/A | N/A | |
![]() biote Corp. NASDAQ:BTMD | 35.19M | 9.4% | 0.9% | N/A | |
![]() Cognition Therapeutics, Inc. NASDAQ:CGTX | -24.59M | N/A | N/A | N/A | |
![]() TuHURA Biosciences, Inc. NASDAQ:HURA | -27.63M | N/A | N/A | N/A | |
![]() The Joint Corp. NASDAQ:JYNT | 1.84M | -50.0% | -33.2% | N/A | |
![]() Lucid Diagnostics Inc. NASDAQ:LUCD | -46.48B | N/A | N/A | N/A |
Continue your DCGO research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.